Evidence map›Paper›PMID 40572788›Full record

ArticleMedicina (Kaunas, Lithuania)2025

"Pre-Treatment" and "Post-Treatment" Systemic Inflammatory Markers: Is There Any Prognostic Role for Metastatic Cervical Cancer on Bevacizumab Containing Treatment?

Serkan Yaşar, Ahmet Kadıoğlu, Arif Akyildiz, Nadiye Sever, Mehmet Emin Büyükbayram, Mehmet Bilici, Elanur Karaman, Mehmet Uzun, Murat Bardakcı, Caglar Koseoglu and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Serkan YaşarDepartment of Medical Oncology, Dr Abdurrahman Yurtaslan Ankara Oncology Training & Research Hospital, University of Health Sciences, 06200 Ankara, Türkiye.ORCID 0000-0002-1465-4131
Ahmet KadıoğluDepartment of Medical Oncology, Dr Abdurrahman Yurtaslan Ankara Oncology Training & Research Hospital, University of Health Sciences, 06200 Ankara, Türkiye.ORCID 0009-0002-4464-314X
Arif AkyildizDepartment of Medical Oncology, Hacettepe University Cancer Institute, 06230 Ankara, Türkiye.ORCID 0000-0002-4452-2076
Nadiye SeverDepartment of Medical Oncology, Faculty of Medicine, Marmara University, 34854 Istanbul, Türkiye.ORCID 0000-0001-7312-3827
Mehmet Emin BüyükbayramDepartment of Medical Oncology, Faculty of Medicine, Atatürk University, 25240 Erzurum, Türkiye.
Mehmet BiliciDepartment of Medical Oncology, Faculty of Medicine, Atatürk University, 25240 Erzurum, Türkiye.ORCID 0000-0003-2850-6997
Elanur KaramanDepartment of Medical Oncology, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, Türkiye.
Mehmet UzunDepartment of Medical Oncology, Institute of Oncology, Dokuz Eylul University, 35340 İzmir, Türkiye.ORCID 0000-0002-8596-4233
Murat BardakcıDepartment of Medical Oncology, Ankara Bilkent City Hospital, 06800 Ankara, Türkiye.ORCID 0000-0001-7854-097X
Caglar KoseogluDepartment of Medical Oncology, Gulhane Training and Research Hospital, University of Health Sciences, 06200 Ankara, Türkiye.
Irem BilgetekinDepartment of Medical Oncology, Memorial Ankara Hospital, 06520 Ankara, Türkiye.
Mehmet Cihan İçliDepartment of Medical Oncology, Hacettepe University Cancer Institute, 06230 Ankara, Türkiye.
Alper TürkelDepartment of Medical Oncology, Dr Abdurrahman Yurtaslan Ankara Oncology Training & Research Hospital, University of Health Sciences, 06200 Ankara, Türkiye.
Zafer ArıkDepartment of Medical Oncology, Hacettepe University Cancer Institute, 06230 Ankara, Türkiye.
Murat SarıDepartment of Medical Oncology, Faculty of Medicine, Marmara University, 34854 Istanbul, Türkiye.ORCID 0000-0003-0596-1559
Tugba YavuzsenDepartment of Medical Oncology, Institute of Oncology, Dokuz Eylul University, 35340 İzmir, Türkiye.
Mehmet Ali Nahit SendurDepartment of Medical Oncology, Ankara Bilkent City Hospital, 06800 Ankara, Türkiye.ORCID 0000-0001-7021-6139
İsmail ErturkDepartment of Medical Oncology, Gulhane Training and Research Hospital, University of Health Sciences, 06200 Ankara, Türkiye.
Mutlu DoganDepartment of Medical Oncology, Dr Abdurrahman Yurtaslan Ankara Oncology Training & Research Hospital, University of Health Sciences, 06200 Ankara, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BevacizumabUterine Cervical NeoplasmsAdultAgedBiomarkersFemaleHumansInflammationMiddle AgedPaclitaxelPrognosisRetrospective StudiesBevacizumabBiomarkersPaclitaxelbevacizumabcervixsystemic inflammatory markers

Identifiers

PMID40572788
PMCPMC12195193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.